- Home
- BOX vs ALKS Comparison
BOX vs ALKS Comparison
Compare BOX & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOX
- ALKS
- Stock Information
- Founded
- BOX 2005
- ALKS 1987
- Country
- BOX United States
- ALKS Ireland
- Employees
- BOX N/A
- ALKS N/A
- Industry
- BOX Computer Software: Prepackaged Software
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- BOX Technology
- ALKS Health Care
- Exchange
- BOX Nasdaq
- ALKS Nasdaq
- Market Cap
- BOX 4.6B
- ALKS 5.1B
- IPO Year
- BOX 2015
- ALKS 1991
- Fundamental
- Price
- BOX $31.79
- ALKS $29.75
- Analyst Decision
- BOX Strong Buy
- ALKS Strong Buy
- Analyst Count
- BOX 9
- ALKS 13
- Target Price
- BOX $38.33
- ALKS $40.38
- AVG Volume (30 Days)
- BOX 1.6M
- ALKS 1.7M
- Earning Date
- BOX 08-26-2025
- ALKS 07-29-2025
- Dividend Yield
- BOX N/A
- ALKS N/A
- EPS Growth
- BOX 77.37
- ALKS 21.99
- EPS
- BOX 1.30
- ALKS 2.08
- Revenue
- BOX $1,101,744,000.00
- ALKS $1,505,296,000.00
- Revenue This Year
- BOX $8.52
- ALKS N/A
- Revenue Next Year
- BOX $7.61
- ALKS $3.33
- P/E Ratio
- BOX $24.50
- ALKS $14.36
- Revenue Growth
- BOX 4.88
- ALKS N/A
- 52 Week Low
- BOX $28.00
- ALKS $25.56
- 52 Week High
- BOX $38.80
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- BOX 47.25
- ALKS 62.54
- Support Level
- BOX $30.42
- ALKS $28.60
- Resistance Level
- BOX $31.82
- ALKS $29.12
- Average True Range (ATR)
- BOX 0.68
- ALKS 0.69
- MACD
- BOX 0.07
- ALKS 0.35
- Stochastic Oscillator
- BOX 70.62
- ALKS 94.60
About BOX Box Inc.
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.